Concepedia

R. Kim

RK

Statistics

Publications

1

Citations

110

H-Index

1

Active since

2021

Affiliations

Samsung (South Korea)(Current)

R. Kim is an author at Samsung (South Korea) specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

2021–2021

1

Publications

1

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy

R. Kim, Minsuk Kwon, Minae An et al. · Annals of Oncology · 2021 · 110 citations · Full text

, , +8

Rows per page

1–1 of 1